April 20, 2026 Biologics Tied to Lower Eye Risk in Psoriasis Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy. Conexiant
March 31, 2026 Equal Pay in Ophthalmology? Not Yet A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks Conexiant
March 24, 2026 Artificial Tears Reduce Dryness Symptoms in 1-Month Study Prospective multicenter study without a control group shows symptom scores reduced by more than half after 4 weeks of treatment Conexiant
March 13, 2026 Dry Eye Across Autoimmune Diseases The nationwide analysis found the highest rates of dry eye disease among patients with Sjögren’s syndrome. Conexiant
March 02, 2026 Why Early NK Treatment Matters Recognizing the importance of early treatment strategies in neurotrophic keratitis The Ophthalmologist
February 17, 2026 Corneal Imaging and an ‘Overlooked Source’ Investigators evaluate how iris pigmentation influences Scheimpflug-derived corneal densitometry measurements. Conexiant
January 01, 2026 Managing Neurotrophic Keratitis Identifying the stage of the condition is crucial to prescribing the best interventions. Optometric Management
October 01, 2025 Integrating Amniotic Membranes Into Practice Drs. Feulner, Milner, and Ayres explain when, why, and how to use amniotic membranes to promote regenerative healing, improve surgical outcomes, and expand treatment options for ocular surface disease. Ophthalmology Management